• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The effect of cPA on carotid intimate-media thickness progression in animal model with atherosclerosis

Research Project

Project/Area Number 25293274
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypePartial Multi-year Fund
Section一般
Research Field General surgery
Research InstitutionNagasaki University (2014-2015)
Kanazawa Medical University (2013)

Principal Investigator

TSUKAHARA Tamotsu  長崎大学, 医歯薬学総合研究科(薬学系), 准教授 (00529943)

Co-Investigator(Kenkyū-buntansha) HANIU Hisao  信州大学, 先鋭領域融合研究群・バイオメディカル研究所, 准教授 (30252050)
MATSUDA Yoshikazu  日本薬科大学, 薬学部, 教授 (20377633)
Co-Investigator(Renkei-kenkyūsha) MUROFUSHI Kimiko  お茶の水女子大学, 学長 (00103557)
Project Period (FY) 2013-04-01 – 2016-03-31
Project Status Completed (Fiscal Year 2015)
Budget Amount *help
¥18,070,000 (Direct Cost: ¥13,900,000、Indirect Cost: ¥4,170,000)
Fiscal Year 2015: ¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2014: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
Fiscal Year 2013: ¥8,580,000 (Direct Cost: ¥6,600,000、Indirect Cost: ¥1,980,000)
Keywords動脈硬化 / 内膜肥厚 / リゾリン脂質 / 核内受容体 / 血管内膜肥厚 / 生理活性脂質 / 動脈硬化症 / 糖尿病
Outline of Final Research Achievements

This study aimed to determine whether metabolically stabilized cPA, in the form of a carba-derivative of cPA (2ccPA), could reduce plasma cholesterol levels and affect the expression of genes related to atherosclerosis in apolipoprotein E-knockout (apoE-/-) mice. 2ccPA reduced LDL-C levels in these mice (n = 3) from 460 to 330 mg/ml, from 420 to 350 mg/ml, and 420 to 281 mg/ml under a western-type diet. 2ccPA also reduced expression of lipid metabolism-related genes, cytokines, and chemokines in ApoE-deficient mice on a high-fat diet. Taken together, these results suggest that 2ccPA governs anti-atherogenic activities in the carotid arteries of apoE-deficient mice.Thus, the results of this study raise the possibility of using cPA as a lead compound to develop new treatments that acton PPARγ; however, further investigation is required to determine the molecular mechanisms underlying the described effect of cPA.

Report

(4 results)
  • 2015 Annual Research Report   Final Research Report ( PDF )
  • 2014 Annual Research Report
  • 2013 Annual Research Report
  • Research Products

    (6 results)

All 2016 2015 2014 2013

All Journal Article (5 results) (of which Peer Reviewed: 5 results,  Acknowledgement Compliant: 4 results,  Open Access: 2 results) Presentation (1 results) (of which Invited: 1 results)

  • [Journal Article] Short-term treatment with a 2-carba analog of cyclic phosphatidic acid induces lowering of plasma cholesterol levels2016

    • Author(s)
      Tamotsu Tsukahara, Hisao Haniu, Yoshikazu Matsuda, and Kimiko Murakami-Murofushi
    • Journal Title

      Biochemical and Biophysical Research Communications

      Volume: 473 Issue: 1 Pages: 107-113

    • DOI

      10.1016/j.bbrc.2016.03.060

    • Related Report
      2015 Annual Research Report
    • Peer Reviewed / Acknowledgement Compliant
  • [Journal Article] Cyclic Phosphatidic Acid inhibits the Secretion of Vascular Endothelial Growth Factor from Diabetic Human Coronary Artery Endothelial Cells through Peroxisome Proliferator-activated Receptor Gamma2015

    • Author(s)
      Tamotsu Tsukahara, Ryoko Tsukahara, Hisao Haniu Yoshikazu Matsuda, and Kimiko Murakami-Murofushi
    • Journal Title

      Molecular and Cellular Endocrinology

      Volume: 412 Pages: 320-329

    • DOI

      10.1016/j.mce.2015.05.021

    • NAID

      120006986899

    • Related Report
      2015 Annual Research Report
    • Peer Reviewed / Acknowledgement Compliant
  • [Journal Article] Heart-type fatty-acid-binding protein (FABP3) is a lysophosphatidic acid-binding protein in human coronary artery endothelial cells.2014

    • Author(s)
      Ryoko Tsukahara, Hisao Haniu, Yoshikazu Matsuda, Tamotsu Tsukahara
    • Journal Title

      FEBS OPEN BIO

      Volume: 4 Issue: 1 Pages: 947-51

    • DOI

      10.1016/j.fob.2014.10.014

    • NAID

      120007110641

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Cyclic Phosphatidic Acid Inhibits Alkyl-Glycerophosphate- Induced Downregulation of Histone Deacetylase 2 Expression and Suppresses the Inflammatory Response in Human Coronary Artery Endothelial Cells2014

    • Author(s)
      Tamotsu Tsukahara, Hisao Haniu, and Yoshikazu Matsuda
    • Journal Title

      International Journal of Medical Sciences

      Volume: 11 Issue: 9 Pages: 955-961

    • DOI

      10.7150/ijms.9316

    • NAID

      120007110639

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Cyclic Phosphatidic Acid: An Endogenous Antagonist of PPARγ2013

    • Author(s)
      Tamotsu Tsukahara, Yoshikazu Matsuda, Hisao Haniu and Kimiko Murakami- Murofushi
    • Journal Title

      Journal of Endocrinology, Diabetes & Obesity

      Volume: 1 Pages: 1005-1005

    • Related Report
      2013 Annual Research Report
    • Peer Reviewed
  • [Presentation] リゾリン脂質を介した新生内膜形成と動脈硬化症2016

    • Author(s)
      塚原 完
    • Organizer
      第25回神経行動薬理若手研究者の集い シンポジウム:健康寿命の延伸を受けた新たなアプローチ
    • Place of Presentation
      埼玉県さいたま市 ソニックシティビル 公益財団法人埼玉県産業文化センター
    • Year and Date
      2016-03-08
    • Related Report
      2015 Annual Research Report
    • Invited

URL: 

Published: 2013-05-21   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi